InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Xenetic Biosciences, Inc.

XBIO Clue Score59
United States Fiscal year ends December CIK 0001534525
$2.13 +0.47% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $2.13 +8.67% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue3.0Operating income−47.4Net income−54.2Fiscal year 2017Revenue7.6 +152.8%Operating income−3.6Net income−3.6Fiscal year 2018Revenue0.0 −100.0%Operating income−7.3Net income−7.3Fiscal year 2019Revenue0.0Operating income−12.9Net income−12.8Fiscal year 2020Revenue0.4 +2,460.3%Operating income−13.9Net income−10.9Fiscal year 2021Revenue1.2 +165.6%Operating income−5.7Net income−5.6EPS, diluted−0.55Fiscal year 2022Revenue1.7 +47.1%Operating income−6.7Net income−6.6EPS, diluted−4.61Fiscal year 2023Revenue2.5 +48.8%Operating income−4.5Net income−4.1EPS, diluted−2.71Fiscal year 2024Revenue2.5 −1.6%Operating income−4.2Net income−4.0EPS, diluted−2.57Fiscal year 2025Revenue3.0 +19.0%Operating income−2.8Net income−2.7EPS, diluted−1.58
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 3.0 7.6 0.0 0.0 0.4 1.2 1.7 2.5 2.5 3.0
Growth +152.8% −100.0% +2,460.3% +165.6% +47.1% +48.8% −1.6% +19.0%
Operating income −47.4 −3.6 −7.3 −12.9 −13.9 −5.7 −6.7 −4.5 −4.2 −2.8
Net income −54.2 −3.6 −7.3 −12.8 −10.9 −5.6 −6.6 −4.1 −4.0 −2.7
Growth
EPS, diluted n/a n/a n/a n/a n/a −0.55 −4.61 −2.71 −2.57 −1.58

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−1,581.0%Net margin−1,806.9%Free cash flow margin−293.5%Fiscal year 2017Operating margin−47.1%Net margin−47.4%Free cash flow margin19.6%Fiscal year 2018Fiscal year 2019Operating margin−75,511.7%Net margin−74,856.6%Fiscal year 2020Operating margin−3,189.8%Net margin−2,493.1%Fiscal year 2021Operating margin−495.1%Net margin−486.4%Fiscal year 2022Operating margin−393.6%Net margin−383.9%Fiscal year 2023Operating margin−177.8%Net margin−162.8%Fiscal year 2024Operating margin−168.2%Net margin−158.4%Fiscal year 2025Operating margin−95.2%Net margin−90.1%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −1,581.0% −47.1% n/a −75,511.7% −3,189.8% −495.1% −393.6% −177.8% −168.2% −95.2%
Net margin −1,806.9% −47.4% n/a −74,856.6% −2,493.1% −486.4% −383.9% −162.8% −158.4% −90.1%
Free cash flow margin −293.5% 19.6% n/a n/a n/a n/a n/a n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−8.8Capital expenditure−0.0Free cash flow−8.8Fiscal year 2017Operating cash flow1.5Capital expenditure−0.0Free cash flow1.5Fiscal year 2018Operating cash flow−6.5Capital expenditure0.0Free cash flow−6.5 −535.3%Fiscal year 2019Operating cash flow−6.4Fiscal year 2020Operating cash flow−4.3Fiscal year 2021Operating cash flow−4.7Fiscal year 2022Operating cash flow−4.6Fiscal year 2023Operating cash flow−4.1Fiscal year 2024Operating cash flow−2.8Fiscal year 2025Operating cash flow−2.3
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −8.8 1.5 −6.5 −6.4 −4.3 −4.7 −4.6 −4.1 −2.8 −2.3
Capital expenditure −0.0 −0.0 0.0 n/a n/a n/a n/a n/a n/a n/a
Free cash flow −8.8 1.5 −6.5 n/a n/a n/a n/a n/a n/a n/a
Growth −535.3%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash4.1Shareholders’ equity16.2Fiscal year 2017Cash5.6Shareholders’ equity14.3Fiscal year 2018Cash0.6Shareholders’ equity9.9Fiscal year 2019Cash10.4Shareholders’ equity17.2Fiscal year 2020Cash11.5Shareholders’ equity12.2Fiscal year 2021Cash18.2Shareholders’ equity18.4Fiscal year 2022Cash13.1Shareholders’ equity13.6Fiscal year 2023Cash9.0Shareholders’ equity9.8Fiscal year 2024Cash6.2Shareholders’ equity6.0Fiscal year 2025Cash7.9Shareholders’ equity7.4
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 4.1 5.6 0.6 10.4 11.5 18.2 13.1 9.0 6.2 7.9
Shareholders’ equity 16.2 14.3 9.9 17.2 12.2 18.4 13.6 9.8 6.0 7.4

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
−8.8 1.5 −6.5 −6.4 −4.3 −4.7 −4.6 −4.1 −2.8 −2.3
Growth −532.6%
Investment
−0.0 −0.0 0.0 n/a n/a n/a n/a n/a n/a n/a
calc −8.8 1.5 −6.5 n/a n/a n/a n/a n/a n/a n/a
Growth −535.3%
−0.0 −0.0 0.0 0.0 0.0 0.0 −0.5 0.0 n/a n/a
Financing
12.7 0.0 1.5 16.1 5.4 11.5 0.0 n/a 0.0 4.0

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.